Please wait a minute...
欢迎访问发育医学电子杂志,今天是
发育医学电子杂志  2022, Vol. 10 Issue (4): 250-260    DOI: 10.3969/j.issn.2095-5340.2022.04.002
  生殖胚胎   论著 |
肌醇缺乏环境下骨形成蛋白/Smad1/5/8通路对小鼠神经干细胞增殖的影响
张妍 杨爱云 李莘 王秀伟 官臻 梁颖超 钟儒刚 王建华 赵丽娇
1. 北京工业大学环境与生命学部 环境与病毒肿瘤学 北京市重点实验室,北京100124;2. 首都儿科研究所转化医学研究室 儿童发育营养组学 北京市重点实验室,北京 100020
Effect of bone morphogenetic proteins/Smad1/5/8 pathway on the proliferation of mouse neural stem cell under inositol deficiency
Zhang Yan, Yang Aiyun, Li Shen, et al
1. Beijing Key Laboratory of Environment and Viral Oncology, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China; 2. Translational Medicine Laboratory, Beijing Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics,Beijing 100020, China
下载:  PDF (1133KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 【摘要】 目的  探究肌醇缺乏环境下骨形成蛋白(bone morphogenetic proteins,BMP)/ 果蝇与秀丽
隐杆线虫蛋白同源物(homologues of the drosophila protein, mothers against decapentaplegic and the
caenorhabditis elegans protein,Smad)1/5/8 通路对小鼠神经干细胞增殖的影响,进一步阐明胚胎神经发
育异常的分子机制。 方法 选取NE-4C 细胞系,分为对照组和0.005、0.01、0.05、0.1、0.5、1、5、10、50、100、150 和200 mmol/L 肌醇处理组;应用肌醇合成酶抑制剂碳酸锂处理细胞,分为对照组和0.75、1、1.25、1.5、1.75、2 和2.5 mmol/L 碳酸锂处理组;用BMP 信号通路抑制剂LDN-193189 进行挽回实验,分别将细胞分为对照组和0.05、0.1、0.5、1、2、4 和8 μmol/L LDN-193189 处理组;以及对照组、碳酸锂组、无肌醇组、碳酸锂+LDN-193189 组和LDN-193189 组,培养24 h,3-(4,5- 二甲基-2- 噻唑)-2,5 - 二苯基四氮唑溴盐[3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide,MTT]法检测各组细胞活性;逆转录- 聚合酶链式反应(reverse transcription-polymerase chain reaction,RT-PCR)检测BMP 信号通路关键基因Bmp2、Bmp4、Smad1、Smad5、Smad8 以及下游靶基因Runx 家族转录因子2(Runx family
transcription factor 2,Runx2)的表达情况;免疫印迹法及免疫荧光检测BMP/Smad1/5/8 通路关键基因的
表达及定位。统计学方法采用方差分析和Dunnett's t 检验。 结果  ① 0.005、0.01、0.05、0.1、0.5、1、5、10、50、100、150 和200 mmol/L 肌醇处理组与对照组细胞活性分别为(119.1±1.5)%、(101.7±2.6)%、(98.9±1.4)%、(101.5±1.2)%、(97.9±1.5)%、(97.5±1.0)%、(96.5±1.2)%、(97.8±1.1)%、(94.4±1.2)%、(92.9±1.9)%、(82.9±1.5)%、(63.6±1.7)% 与(147.8±2.4)%,随着培养基中肌醇浓度增加,细胞增殖能力逐渐降低(P 值均<0.01)。1、1.25、1.5、1.75、2 和2.5 mmol/L 碳酸锂处理组与对照组细胞活性分别为(119.8±1.6)%、(128.1±1.8)%、(138.5±2.2)%、(114.4±2.3)%、(111.0±1.9)%、(106.3±1.7)% 与(99.5±1.6)%,
碳酸锂显著促进细胞增殖(P 值均<0.05),且浓度为1.5 mmol/L 时细胞增殖作用最明显。②碳酸锂组、
无 肌 醇 组 与 对 照 组 Bmp2( 2.17±0.26、19.81±0.92 与 1.00±0.13)、Bmp4(1.97±0.18、4.23±0.31 与1.00±0.27)、Smad1(1.91±0.15、4.10±0.25 与1.00±0.37)、Smad5(1.94±0.20、2.88±0.27 与1.00±0.28)、Smad8(1.62±0.14、3.20±0.18 与1.00±0.13)及Runx2(1.79±0.13、5.31±0.49 与1.00±0.21)的mRNA水平比较,碳酸锂组和无肌醇组基因表达增强(P 值均<0.01)。③ 0.05、0.1、0.5、1、2、4 和8 μmol/L LDN-193189 处理组与对照组细胞活性分别为(96.5±0.7)%、(80.4±1.6)%、(63.8±1.1)%、(56.9±1.8)%、(29.3±2.4)%、(4.6±0.2)%、(2.6±0.2)% 与(99.4±1.0)%,LDN-193189 抑制细胞增殖且具有剂量依赖性(P值均<0.001)。碳酸锂组、无肌醇组、碳酸锂+LDN-193189 组、无肌醇+LDN-193189 组、LDN-193189组与对照组细胞活性分别为(122.1±2.0)%、(144.7±2.7)%、(82.6±2.3)%、(66.6±2.0)%、(57.3±2.1)%与(101.2±2.2)%,LDN-193189 能逆转碳酸锂或无肌醇诱导的细胞增殖(P 值均<0.001)。④ 碳酸锂
组、无肌醇组、碳酸锂+LDN-193189 组、LDN-193189 组与对照组磷酸化Smad1/5/8 相对表达量分别为
1.30±0.10、1.62±0.10、0.59±0.15、0.11±0.08 与1.00±0.18,表明LDN-193189 能逆转肌醇缺乏环境下
磷酸化Smad1/5/8 蛋白表达上调(P<0.01)。⑤免疫荧光结果显示,红色荧光标记的Runx2 蛋白定位于细
胞核,与对照组比较,碳酸锂组和无肌醇组Runx2 表达增高,LDN-193189 组几乎无表达,碳酸锂+LDN-
193189 组表达降低,LDN-193189 能逆转肌醇缺乏环境下诱导的Runx2 表达上调。碳酸锂组、无肌醇组、
碳酸锂+LDN-193189组、LDN-193189组与对照组Runx2 蛋白相对表达量分别为2.00±0.08、2.09±0.11、
1.75±0.05、1.76±0.13 与1.04±0.10,表明肌醇缺乏促进Runx2 表达上调(P<0.01),LDN-193189 逆转碳
酸锂诱导的Runx2 表达上调的作用不明显,但P 值接近0.05(P=0.051)。 结论 肌醇缺乏环境会导致
BMP/Smad1/5/8 通路被异常激活,调控下游靶基因Runx2,可促进神经干细胞异常增殖。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词:  骨形成蛋白类  肌醇  神经干细胞  细胞增殖  信号传导    
Abstract: 【Abstract】 Objective To explore the effect of bone morphogenetic protein (BMP) / homologues of
the drosophila protein, mothers against decapentaplegic and the caenorhabditis elegans protein (Smad)
1/5/8 pathway on the proliferation of mouse neural stem cell (mNSC) under inositol deficiency, for further
clarifying the molecular mechanism of embryonic neurodevelopmental abnormalities. Method NE-
4C cell line was selected, divided into control group and 0.005, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 50, 100, 150
and 200 mmol/L inositol treatment groups. The cells were treated with lithium carbonate, an inhibitor of
inositol monophosphatase that interfered with inositol synthesis, which were divided into control group and
0.75, 1, 1.25, 1.5, 1.75, 2 and 2.5 mmol/L lithium carbonate treatment groups. The recovery experiment
was carried out with BMP signaling pathway inhibitor LDN-193189, and the cells were divided into control
group and 0.05, 0.1, 0.5, 1, 2, 4 and 8 μmol/L LDN-193189 treatment groups, and divided into control
group, lithium carbonate group, inositol free group, lithium carbonate+LDN-193189 group and LDN-
193189 group respectively, which were cultured for 24 h, the cell activity of each group was detected by
3-(4,5-dimethylthiazol-2-yl)-2,5-di-phenyltetrazolium bromide (MTT) method. Reverse transcriptionpolymerasechain reaction (RT-PCR) was used to detect the expressions of key genes Bmp2, Bmp4, Smad1,Smad5, Smad8, and downstream target gene Runx family transcription factor 2 (Runx2) of BMP signalingpathway. The expressions and localization of key genes of BMP/Smad1/5/8 pathway were detected byWestern blotting and immunofluorescence. Statistical methods performed by analysis of Variance andDunnett's t test.  Result ① The cell activities in 0.005, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 50, 100, 150, 200mmol/L inositol treatment groups and control group were as follows: (119.1±1.5)%, (101.7±2.6)%,(98.9±1.4)%, (101.5±1.2)%, (97.9±1.5)%, (97.5±1.0)%, (96.5±1.2)%, (97.8±1.1)%, (94.4±1.2)%,(92.9±1.9)%, (82.9±1.5)%, (63.6±1.7)% and (147.8±2.4)%, the cell proliferation ability decreased gradually with the increase of inositol concentration in the culture medium (all P<0.01). The cell activitiesin 1, 1.25, 1.5, 1.75, 2, 2.5 mmol/L lithium carbonate treatment groups and control group were as follows:(119.8±1.6)%, (128.1±1.8)%, (138.5±2.2)%, (114.4±2.3)%, (111.0±1.9)%, (106.3±1.7)% and
(99.5±1.6)%, lithium carbonate significantly promoted cell proliferation (all P<0.05), and the effect on
cell proliferation was the most obvious at 1.5 mmol/L. ② The mRNA levels in lithium carbonate group,
inositol free group and control group were as follows: Bmp2 (2.17±0.26, 19.81±0.92 and 1.00±0.13),
Bmp4 (1.97±0.18, 4.23±0.31 and 1.00±0.27), Smad1 (1.91±0.15, 4.10±0.25 and 1.00±0.37), Smad5
(1.94±0.20, 2.88±0.27 and 1.00±0.28), Smad8 (1.62±0.14, 3.20±0.18 and 1.00±0.13) and Runx2
(1.79±0.13, 5.31±0.49 and 1.00±0.21), which were enhanced in both lithium carbonate group and inositol
free group (all P<0.01). ③ The cell activities in 0.05, 0.1, 0.5, 1, 2, 4, 8 μmol/L LDN-193189 treatment
groups and control group were as follows: (96.5±0.7)%, (80.4±1.6)%, (63.8±1.1)%, (56.9±1.8)%,
(29.3±2.4)%, (4.6±0.2)%, (2.6±0.2)% and (99.4±1.0)%, LDN-193189 inhibited cell proliferation in a dosedependentmanner (all P<0.001). The cell activities in lithium carbonate group, inositol free group, lithium carbonate+LDN-193189 group, LDN-193189 treatment groups and control group were as follows: (122.1±2.0)%,(144.7±2.7)%, (82.6±2.3)%, (66.6±2.0)%, (57.3±2.1)% and (101.2±2.2)%, LDN-193189 could reversethe cell proliferation induced by lithium carbonate or inositol free (all P<0.001). ④ The relative expressions ofphospho-Smad1/5/8 in lithium carbonate group, inositol free group, lithium carbonate+LDN-193189 group, LDN-193189 treatment groups and control group were as follows: 1.30±0.10, 1.62±0.10, 0.59±0.15, 0.11±0.08and 1.00±0.18, which indicated that LDN-193189 could reverse the up-regulation of phospho-Smad1/5/8 proteinexpression under inositol deficiency (P<0.01). ⑤ The results of the immunofluorescence showed that the redfluorescent labeled Runx2 protein was localized in the nucleus. Compared with control group, the expressionsof Runx2 were increased in both lithium carbonate group and inositol free group, almost no expression in LDN-193189 group, and decreased in lithium carbonate+LDN-193189 group. LDN-193189 could reverse the upregulationof Runx2 expression under inositol deficiency. The relative expressions of Runx2 protein in lithiumcarbonate group, inositol free group, lithium carbonate+LDN-193189 group, LDN-193189 treatment groups andcontrol group were as follows: 2.00±0.08, 2.09±0.11, 1.75±0.05, 1.76±0.13 and 1.04±0.10, which indicatedthat inositol deficiency promoted up-regulation of Runx2 expression (P<0.01), and the effect that LDN-193189
reversed the up-regulation of Runx2 expression induced by lithium carbonate was not significant, but P valuewas close to 0.05 (P=0.051). Conclusion Inositol deficiency leads to abnormal activation of BMP/Smad1/5/8pathway, regulates downstream target gene Runx2, and promots abnormal proliferation of neural stem cell.
Key words:  Bone morphogenetic proteins    Inositol    Neural stem cell    Cell proliferation    Signaltransduction
收稿日期:  2022-03-07                     发布日期:  2022-07-29     
基金资助: 北京市自然科学基金(7222016);首都儿科研究所所级基金(CXYJ-2021-03)
通讯作者:  王建华;赵丽娇    E-mail:  fywjh@163.com zhaolijiao@bjut.edu.cn
引用本文:    
张妍 杨爱云 李莘 王秀伟 官臻 梁颖超 钟儒刚 王建华 赵丽娇. 肌醇缺乏环境下骨形成蛋白/Smad1/5/8通路对小鼠神经干细胞增殖的影响[J]. 发育医学电子杂志, 2022, 10(4): 250-260.
Zhang Yan, Yang Aiyun, Li Shen, et al. Effect of bone morphogenetic proteins/Smad1/5/8 pathway on the proliferation of mouse neural stem cell under inositol deficiency. Journal of Developmental Medicine(Electronic Version), 2022, 10(4): 250-260.
链接本文:  
http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2022.04.002  或          http://www.fyyxzz.com/CN/Y2022/V10/I4/250
[1] 李紫袁 李文. 体外激活治疗早发性卵巢功能不全的研究进展[J]. 发育医学电子杂志, 2022, 10(1): 58-63.
[2] 李莘 牛勃 王建华. Ⅰ型磷脂酰肌醇 4- 磷酸 5- 激酶在神经发育性疾病中的作用及其机制研究[J]. 发育医学电子杂志, 2018, 6(2): 112-116.
[3] 魏晓伟 袁正伟. 反式维甲酸诱导显性脊柱裂胎鼠骶尾部 神经前体细胞凋亡和增殖的变化规律研究[J]. 发育医学电子杂志, 2015, 3(1): 42-46.
[4] 朱莎莎 刘雪华 余章斌 朱春 李萌萌 韩树萍 胡晓山 朱金改 彭宇竹. miR-20b过表达对P19细胞增殖和细胞分化的影响[J]. 发育医学电子杂志, 2014, 2(2): 87-92.
[1] Society of Neonatologist, Chinese Medical Doctor Association. Consensus recommendations on the prevention and early management of respiratory distress syndrome in preterm infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 129 -131 .
[2] Professional Committee of Respiratory, Society of Neonatologist, Chinese Medical Doctor Association. Clinical application recommendations for heated humidified high flow nasal cannula[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 132 -135 .
[3] YAN Jun, ZHU Xing-wang, SHI Yuan. Application progress of noninvasive ventilate technique for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 136 -140 .
[4] GU Min-fang, YANG Chuan-zhong. Progress of intrapartum resuscitation for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 141 -145 .
[5] LIU Shu-hua, SHEN Yue-bo, LIU Cui-qing, MA Li. The efficacy of pulmonary surfactant for pulmonary function in premature tension pneumothorax[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 146 -151 .
[6] GAO Xiao-hui, MAO Jian. Clinical features of non-oliguric hyperkalemia in extremely low birth weight infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 152 -158 .
[7] XIA Yao-fang, YANG Juan , TIAN Bao-li, et al. Value of amplitude-integrated electroencephalography in monitoring acute period of neonatal bilirubin encephalopathy and prognostic assessment[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 159 -163 .
[8] WANG Li-rong, SUN Xiao-yan, ZHU Ruo-xin, et al. Epidemiological investigation and analysis of women aged 40-55 years old with osteoporosis in Gansu province[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 164 -167 .
[9] CHEN Ru-yue, SHEN Yun-yan, CHEN Qing , et al. Five cases about Henoch-Schönlein purpura complicated with central nervous system injury in children and literatures review[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 168 -171 .
[10] ZHANG Ai-run, FANG Xiao-yi. Lung function testing of bronchopulmonary dysplasia for infants and children[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 172 -176 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed